The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.
Filter by category
- All
- Blog
- Congress
- Scientific resource
- Webinar
- Poster
- Scientific publication
- Press release
- Press coverage
- News
Filter by category
Poster
28/04/2025
Pharmacological evaluation using the AbYlink TM regio-selective conjugation technology
AbYlink is a regio-selective labeling method, enabling a one-step conjugation of payloads to the Fc domain of an antibody. Read the poster!
Poster
28/04/2025
PDX-Derived Organoids: Insights into Cancer Stem Cells and Metastasis
Our study highlights the versatility and translational relevance of PDXOs in cancer research. Read the poster!
News
24/04/2025
Debiopharm and Oncodesign Services Launch Strategic Collaboration
Debiopharm and Oncodesign Services announce the execution of a license agreement for the use of the AbYlink technology
Blog
23/04/2025
Radioligand Binding Assays: A Lost Art in Drug Discovery?
Old-school or still essential? Explore the overlooked power of radioligand binding assays in today's research environment.
Webinar
16/04/2025
Webinar – Hidden Potential: Using Fragments to Uncover New Ligandable Sites on Popular Targets
Learn how fragments reveal novel opportunities in well-known drug targets. Watch the webinar to explore strategies, case studies, and actionable insights.
Scientific resource
15/04/2025
White Paper: Discovering & Advancing Molecular Glues Using a Cooperativity-Based Approach
Discover how a cooperativity-driven approach accelerates molecular glue discovery. Download the white paper to learn more about the science and strategy.
Scientific resource
07/04/2025
PDX Research Model Guide
Explore 200+ PDX models across 14 indications. Better predict clinical response with fully characterized, customizable models. Download now.
Press release
31/03/2025
Oncodesign Services appoints Aidan Synnott as CEO to enhance strategic drug discovery partnerships
Oncodesign Services has appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its position as a trusted partner in drug discovery.
Scientific publication
28/03/2025
Publication: The Nature of Nanodisc Lipids Influences Fragment-Based Drug Discovery Results
Discover how nanodisc lipids impact fragment-based drug discovery, enhancing membrane protein screening and enabling new therapeutic possibilities.
News
27/03/2025
Oncology CRO of the Year 2025 – France
Oncodesign Services wins "Oncology CRO of the Year 2025 – France" for the second year, highlighting excellence in drug discovery and preclinical oncology research.
Blog
06/03/2025
Cooperativity: The Missing Link in Molecular Glue Discovery
In this Q&A, discover how cooperativity is unlocking new potential in molecular glues and enabling the targeting of previously “undruggable” proteins.
Scientific resource
03/03/2025
Case study: Capturing out-of-range target engagement kinetics for an advanceable clinical candidate
Characterizing the inhibition of PRMT5:MTA by MRTX1719, a clinical stage MTAP-deleted cancer therapeutic.